Rasagiline
Showing 1 - 25 of 69
REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies Trial (Rasagiline)
Not yet recruiting
- REM Sleep Behavior Disorder
- +2 more
- Rasagiline
- (no location specified)
Nov 6, 2022
Results Survey "Survey on Long-term Safety"
Completed
- Parkinson's Disease
- Rasagiline
-
Tokyo, JapanTakeda Selected Site
Nov 2, 2021
Depressive Symptoms, Parkinson's Disease Trial in Italy (Rasagiline, Placebo)
Completed
- Depressive Symptoms
- Parkinson's Disease
- Rasagiline
- Placebo
-
Cagliari, Italy
- +11 more
Aug 30, 2021
Safinamide, Rasagiline and Other Standard of Care in PD
Recruiting
- Parkinson's Disease
-
Berlin, Germany
- +2 more
Aug 9, 2021
Parkinson's Disease Trial in Gainesville (drug, other, device)
Active, not recruiting
- Parkinson's Disease
- Rasagiline
- +4 more
-
Gainesville, FloridaLaboratory for Rehabilitation Neuroscience
Nov 12, 2021
Parkinson's Disease Trial in United States (Rasagiline, Placebo)
Completed
- Parkinson's Disease
- Rasagiline
- Placebo
-
Birmingham, Alabama
- +39 more
Nov 6, 2021
Amyotrophic Lateral Sclerosis (ALS) Trial in United States (Rasagiline, Placebo)
Completed
- Amyotrophic Lateral Sclerosis (ALS)
- Rasagiline
- Placebo
-
Phoenix, Arizona
- +9 more
Jan 14, 2020
Schizophrenia Trial in Baltimore, Catonsville, Dundalk (rasagiline (Pharmacodynamics), Placebo)
Completed
- Schizophrenia
- rasagiline (Pharmacodynamics)
- Placebo
-
Baltimore, Maryland
- +4 more
Sep 23, 2019
Parkinson Disease, Early Parkinson's Disease Trial in Worldwide (P2B001, Rasagiline, Pramipexole)
Active, not recruiting
- Parkinson Disease
- Early Parkinson's Disease
- P2B001
- +3 more
-
Scottsdale, Arizona
- +71 more
May 20, 2021
MDD, Treatment Resistant Depression Trial in Toronto ([11C]SL25.1188 PET radiotracer)
Recruiting
- Major Depressive Disorder
- Treatment Resistant Depression
- [11C]SL25.1188 PET radiotracer
-
Toronto, Ontario, CanadaCAMH
Mar 31, 2022
Healthy Volunteers Trial in Anaheim (Placebo, Rasigiline, Phenelzine)
Recruiting
- Healthy Volunteers
- Placebo
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials
Oct 13, 2021
2.5 Years of Rasagiline Therapy on Progression of Cognitive
Completed
- Parkinson's Disease
- Rasagiline
-
Buffalo, New YorkUniversity at Buffalo
Apr 14, 2019
Retinal Detachment Trial in Bern (Rasagiline, Placebo)
Terminated
- Retinal Detachment
- Rasagiline
- Placebo
-
Bern, SwitzerlandDepartment of Ophthalmology, Bern University Hospital
Feb 18, 2019
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy Trial in Loma Linda (Droxidopa, Placebo Oral Tablet)
Withdrawn
- Parkinson Disease
- +2 more
- Droxidopa
- Placebo Oral Tablet
-
Loma Linda, CaliforniaLoma Linda University Faculty Medical Offices - Neurology Clinic
Feb 14, 2022
Amyotrophic Lateral Sclerosis (ALS) Trial in Canada, United States (rasagiline)
Completed
- Amyotrophic Lateral Sclerosis (ALS)
- rasagiline
-
Phoenix, Arizona
- +9 more
Apr 17, 2018
Amyotrophic Lateral Sclerosis (ALS) Trial in Dallas (Antioxidants)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
- Antioxidants
-
Dallas, TexasVA North Texas Health Care System
Mar 25, 2022
Multiple System Atrophy Trial in London (Exenatide Pen Injector [Bydureon])
Recruiting
- Multiple System Atrophy
- Exenatide Pen Injector [Bydureon]
-
London, United KingdomLeonard Wolfson Experimental Neurology Centre, National Hospital
Nov 4, 2020
ALS Trial in Kansas City (Oxaloacetic Acid)
Unknown status
- ALS
- Oxaloacetic Acid
-
Kansas City, KansasUniversity of Kansas Medical Center
Dec 17, 2019
Parkinson's Disease Trial in Israel, United States (P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),, Placebo,
Completed
- Parkinson's Disease
- P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),
- +2 more
-
Birmingham, Alabama
- +28 more
Oct 30, 2017
Azilect + Antidepressant Chart Review
Completed
- Serotonin Syndrome
- Group R+AD Rasagiline + Antidepressant
- +2 more
- (no location specified)
Feb 2, 2017